FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Vitamin A Palmitate (Aquasol A) Injection
Status: Currently in Shortage
»Date first posted: 10/21/2021
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology

Casper Pharma, LLC (New 10/21/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50,000 USP units/mL (15 mg retinol), single dose vial (NDC 61703-418-18) Anticipated availability: January 2022 Delay is due to manufacturing delays at the contract manufacturing facility. Manufacturing delay

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English